Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism
Top Cited Papers
- 1 January 2003
- Vol. 32 (1) , 1-7
- https://doi.org/10.1016/s8756-3282(02)00915-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Circulating IL‐6‐type cytokines and sIL‐6R in patients with multiple myelomaBritish Journal of Haematology, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.The Journal of Experimental Medicine, 1996
- Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout diseaseJournal of Clinical Endocrinology & Metabolism, 1996
- New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: Roles of IL-6 and gp130International Journal of Immunopharmacology, 1995
- Interleukin-11: a new cytokine critical for osteoclast development.Journal of Clinical Investigation, 1994
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- Perspectives: Interleukin-6: An osteotropic factor?Journal of Bone and Mineral Research, 1992
- Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.Journal of Clinical Investigation, 1992
- Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariaeJournal of Bone and Mineral Research, 1991